Caplight Directory>Companies>Fathom Therapeutics-preview>Fathomtx


Fathom Therapeutics

Fathom Therapeutics

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.fathomtx.com/

Last Round

Series A

Apr 27, 2026

Total Funding Raised

$47M

Company Overview

Fathom Therapeutics is a biotechnology company that uses physics-based simulations and AI to design novel drug molecules by modeling protein motion and interactions at the atomic level.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Revenue Share

AI Layer

Application

Keywords

AI drug discoverysmall molecule discoveryprotein dynamicsundruggable targetsphysics-based simulationcomputational drug discoveryin silico drug discoverymolecular dynamicsdrug design platformquantum chemistrydiscovery partnershipsprotein degraders

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fathom Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fathom Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 27, 2026
View all Funding Rounds

Fathom Therapeutics Investors

Notable investors and investment history

InvestorRounds
Chemistry VCSeries A
Alexandria Venture InvestmentsSeries A
New York VenturesSeries A
Sutter Hill VenturesSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    $47M round led by Sutter Hill Ventures.

View all signals

Fathom Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fathom Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fathom Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2023
Last FundingApr 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.